Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti–TIM-3 therapy in mice

Talvard-Balland N, Braun LM, Dixon KO, Zwick M, Engel H, Hartmann A, Duquesne S, Penter L, Andrieux G, Rindlisbacher L, Acerbis A, Ehmann J, Köllerer C, Ansuinelli M, Rettig A, Moschallski K, Apostolova P, Brummer T, Illert AL, Schramm MA, Cheng Y, Köttgen A, Duyster Y, Menssen HD, Ritz J, Blazar BR, Boerries M, Schmitt-Gräff A, Sariipek N, Van Galen N, Buescher JM, Cabezas-Wallscheid N, Pahl HL, Pearce EL, Soiffer EJ, Wu CJ, Vago L, Becher B, Köhler N, Wertheimer T,Kuchroo VK, and Zeiser R: Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti–TIM-3 therapy in mice. J Clin Invest 134(16):e177460; doi: 10.1172/JCI177460 (2024).

Categorised in:

This post was written by redakteur